Immugenia is an early-stage immuno-oncology company.
Business Model:
Revenue: $0
Employees: 1-10
Address: 3000 Boul. de l’Université P1-ACET
City: Sherbrooke
State: quebec
Zip: J1K 0A5
Country: CA
Immugenia is an early-stage immuno-oncology company developing a novel approach to CAR therapy by engineering hematopoietic stem cells to treat cancer and prevent relapses.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Pre-Seed | - | 10/2022 | Pre Seed Round | - |
ACET Capital adMare Bio Innovations Sherbrooke Innopole ACET Capital adMare Bio Innovations Sherbrooke Innopole |
10/2022 | Pre-Seed | - |
adMare BioInnovations ACET Capital 2 Sherbrooke Innopole adMare BioInnovations ACET Capital 2 Sherbrooke Innopole |
10/2022 | Pre Seed Round | 3 | - |
ACET Capital adMare Bio Innovations Sherbrooke Innopole ACET Capital adMare Bio Innovations Sherbrooke Innopole |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|